Mednet Logo
SpecialtiesRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

Do you offer adjuvant radiation therapy for patients with hepatocellular carcinoma status post partial hepatectomy with positive parenchymal margins?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan-Kettering Cancer Center

The answer to this question had changed in my mind with the advent of ablative doses and techniques. If the postop scan does not show bowel near the area that you estimate to be at risk, I would observe and offer an ablative dose if there was an isolated recurrence. The competing risks of DM and liv...

Would you treat the axilla and supraclav in a recurrent breast cancer that presented in the breast and IMNs that had comprehensive breast/node radiation many years ago?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Beth Israel Deaconess Medical Center

Not for prophylaxis -the risk of complications is too high. I would reserve RT for treatment of symptomatic lesions not otherwise manageable by surgery or systemic therapy.

What dose and fractionation do you utilize for node positive HCC?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan-Kettering Cancer Center

First thing to point out is that the evidence for an oligometastatic state for HCC is limited. In general, however, I would still recommend definitive RT for limited hilar or infradiaphragmatic nodal spread. The 2 approaches are: 5 fraction SBRT with dose reduction based on the mean liver dose and ...

How would you treat a young patient with an EGFR 19 deletion and a locally advanced lung mass who had a brain metastasis that was resected?

3 Answers

Mednet Member
Mednet Member
Medical Oncology · University of Colorado Anschutz Medical Center

The technically correct, textbook answer would be 1st line EGFR therapy for metastatic NSCLC, which would be osimertinib + carboplatin/pemetrexed (FLAURA2) or amivantamab/lazertinib (MARIPOSA). However, given the unique circumstances here, I would treat this patient slightly differently.I've written...

Would you consider radiating an unresectable intimal sarcoma if it involved the valves of the great vessels?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Arkansas for Medical Sciences

First, I would quickly confirm that the patient is truly unresectable. I've seen complex cases deemed unresectable and therefore palliative at very fine institutions that were subsequently treated definitively after a second opinion at a center of peak surgical expertise. It is worth recognizing tha...

In ES-SCLC presenting with limited asymptomatic brain metastases and treated upfront with systemic therapy alone (carbo/etop/atezo), how would you approach the brain if MRI shows PR after a few cycles?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Dana Farber/Brigham and Women's Cancer Center

In our practice, we would typically watch such a patient on systemic therapy. However, we would stress the need for vigilant monitoring and likely administration of RT (SRS ideally) at the carbo/etop/atezo transition to atezo monotherapy, given the poor intracranial efficacy of the maintenance syste...

Would you offer local radiotherapy to prostate in a patient with small cell neuroendocrine carcinoma who had a complete response to chemotherapy?

4
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Cleveland Clinic Florida

Thank you for this great question. Yes, I would strongly consider radiation therapy to the prostate and pelvic LNs for small cell carcinoma of the prostate. Small cell carcinomas of the prostate are rare and comprise <1% of all prostate cancers and are known to be more aggressive. They are often unr...

How would you approach a patient with vitreoretinal lymphoma without CNS or systemic involvement?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

The optimal treatment approach for primary intraocular lymphoma is debated. This is a rare disease with only small retrospective series guiding therapy. There is no clear superior treatment approach in the literature. In clinical practice, younger patients are often treated initially with high-dose ...

Would you recommend adjuvant radiation therapy to the locoregional lymph node basins for Merkel cell carcinoma (MCC) s/p WLE with negative margins and isolated tumor cells in 1 of 3 right inguinal sentinel lymph nodes?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas at Tyler

Yes, this is not an easy disease to cure in the node-positive setting. So, the question can be framed: do isolated tumor cells constitute a benign finding, frank malignancy, or a space in between? I don't have an answer to that, and perhaps given the rarity of the entity, that answer will remain rec...

How is your approach to a patient referred for radiotherapy for keloids with a history of Beals syndrome?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Although of theoretical concern, I am not aware of any contraindication to RT (treatment philosophy similar to Ehlers-Danlos syndrome).